AKT1 and neoplasm: By increasing the infiltration of M1 TAMs in tumor tissues, the ratio of M1/M2 TAMs within the TME was altered, which in turn increased the sensitivity of tumor cells to capecitabine.[109] Recently, the AKT signaling pathway has become heavily researched in tumor immunotherapy because drugs targeting this pathway affect the polarization of TAMs.